• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study.当代生存终点:一项国际弥漫性固有脑桥胶质瘤注册研究。
Neuro Oncol. 2017 Sep 1;19(9):1279-1280. doi: 10.1093/neuonc/nox107.
2
External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry.弥漫性脑桥内在型胶质瘤生存预测模型的外部验证:来自国际弥漫性脑桥内在型胶质瘤注册中心和欧洲小儿肿瘤学会弥漫性脑桥内在型胶质瘤注册中心的联合报告
J Neurooncol. 2017 Aug;134(1):231-240. doi: 10.1007/s11060-017-2514-9. Epub 2017 May 30.
3
A Phase 1/2 Trial of Reirradiation for Diffuse Intrinsic Pontine Glioma.复发后再放疗治疗弥漫性内生脑桥胶质瘤的 1/2 期临床试验。
Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):144-148. doi: 10.1016/j.ijrobp.2018.12.043. Epub 2019 Jan 2.
4
Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium.表观扩散系数直方图指标与弥漫性脑桥内在胶质瘤的生存率相关:来自儿童脑肿瘤协作组的报告
Neuro Oncol. 2016 May;18(5):725-34. doi: 10.1093/neuonc/nov256. Epub 2015 Oct 20.
5
Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.首次进展时行再放疗的弥漫性内在脑桥胶质瘤(DIPG)患者的生存获益:代表 SIOP-E-HGG/DIPG 工作组的匹配队列分析。
Eur J Cancer. 2017 Mar;73:38-47. doi: 10.1016/j.ejca.2016.12.007. Epub 2017 Feb 3.
6
Clinical approach to re-irradiation for recurrent diffuse intrinsic pontine glioma.复发性弥漫性内在脑桥胶质瘤再放疗的临床方法。
Jpn J Clin Oncol. 2021 Apr 30;51(5):762-768. doi: 10.1093/jjco/hyab006.
7
Prolonged survival after treatment of diffuse intrinsic pontine glioma with radiation, temozolamide, and bevacizumab: report of 2 cases.弥漫性脑桥内在型胶质瘤经放疗、替莫唑胺和贝伐单抗治疗后的长期生存:2例报告
J Pediatr Hematol Oncol. 2013 Jan;35(1):e42-6. doi: 10.1097/MPH.0b013e318279aed8.
8
Diffuse intrinsic pontine glioma biopsy: a single institution experience.弥漫性脑桥内生型胶质瘤活检:单机构经验
Pediatr Blood Cancer. 2015 Jan;62(1):163-5. doi: 10.1002/pbc.25224. Epub 2014 Sep 27.
9
Main editor's comment to the paper: the response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma. Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek.主编对该论文的评论:基于抗瘤酮A10和AS2-1对脑干胶质瘤患者的II期研究,复发性弥漫性脑桥胶质瘤患儿的反应和生存情况。斯坦尼斯瓦夫·R·布尔津斯基、托马什·J·亚尼基、格雷戈里·S·布尔津斯基、阿尼亚·马尔沙莱克
Childs Nerv Syst. 2014 Dec;30(12):2063. doi: 10.1007/s00381-014-2513-5. Epub 2014 Aug 6.
10
Hypofractionated Radiotherapy for Children With Diffuse Intrinsic Pontine Gliomas.儿童弥漫性脑桥内生型胶质瘤的大分割放疗
Pediatr Blood Cancer. 2016 Apr;63(4):716-8. doi: 10.1002/pbc.25836. Epub 2015 Nov 6.

引用本文的文献

1
The oncolytic adenovirus Ad-TD-nsIL12 in primary or progressive pediatric IDH wild-type diffuse intrinsic pontine glioma results of two phase I clinical trials.溶瘤腺病毒Ad-TD-nsIL12治疗原发性或进展性儿童异柠檬酸脱氢酶野生型弥漫性脑桥胶质瘤的两项I期临床试验结果
Nat Commun. 2025 Jul 28;16(1):6934. doi: 10.1038/s41467-025-62260-5.
2
Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomas.靶向CD40共刺激受体以提高弥漫性中线胶质瘤的病毒治疗疗效。
Cell Rep Med. 2025 Jul 15;6(7):102204. doi: 10.1016/j.xcrm.2025.102204. Epub 2025 Jun 26.
3
Targeting the HLA-E-NKG2A axis in combination with MS-275 enhances NK cell-based immunotherapy against DMG.靶向HLA-E-NKG2A轴并联合MS-275可增强基于NK细胞的针对弥漫性中线胶质瘤的免疫治疗。
J Exp Clin Cancer Res. 2025 Apr 29;44(1):133. doi: 10.1186/s13046-025-03390-y.
4
A Multicenter Phase II Trial of Nimustine Hydrochloride Administered via Convection-Enhanced Delivery in Children With DIPG.一项关于盐酸尼莫司汀经对流增强递送用于弥漫性内生型脑桥胶质瘤儿童患者的多中心II期试验。
Cancer Sci. 2025 Jun;116(6):1679-1690. doi: 10.1111/cas.70054. Epub 2025 Mar 27.
5
GABAergic neuron-to-glioma synapses in diffuse midline gliomas.弥漫性中线胶质瘤中的γ-氨基丁酸能神经元与胶质瘤突触
Nature. 2025 Mar;639(8056):1060-1068. doi: 10.1038/s41586-024-08579-3. Epub 2025 Feb 19.
6
Advancements in targeted and immunotherapy strategies for glioma: toward precision treatment.神经胶质瘤靶向治疗和免疫治疗策略的进展:迈向精准治疗
Front Immunol. 2025 Jan 14;15:1537013. doi: 10.3389/fimmu.2024.1537013. eCollection 2024.
7
Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial.用于弥漫性脑桥内在型胶质瘤的脑室内靶向B7-H3嵌合抗原受体T细胞:一项1期试验
Nat Med. 2025 Mar;31(3):861-868. doi: 10.1038/s41591-024-03451-3. Epub 2025 Jan 7.
8
Intravenous and intracranial GD2-CAR T cells for H3K27M diffuse midline gliomas.用于H3K27M弥漫性中线胶质瘤的静脉内和颅内GD2嵌合抗原受体T细胞
Nature. 2025 Jan;637(8046):708-715. doi: 10.1038/s41586-024-08171-9. Epub 2024 Nov 13.
9
Retrospective Comparison of Targeted Anticancer Drugs Predicted by the CNS-TAP Tool Versus Those Selected by a Molecularly Driven Tumor Board in Children With DIPG.中枢神经系统肿瘤治疗评估预测工具(CNS-TAP)预测的靶向抗癌药物与分子驱动的肿瘤委员会为弥漫性内在性脑桥胶质瘤(DIPG)患儿选择的靶向抗癌药物的回顾性比较
J Pediatr Hematol Oncol. 2025 Jan 1;47(1):19-30. doi: 10.1097/MPH.0000000000002964. Epub 2024 Nov 6.
10
Advances in Molecular Pathology, Diagnosis and Treatment of Spinal Cord Astrocytomas.脊髓星形细胞瘤的分子病理学、诊断和治疗进展。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241262483. doi: 10.1177/15330338241262483.

本文引用的文献

1
The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease.国际弥漫性固有脑桥胶质瘤注册库:加速罕见病合作研究的基础设施。
J Neurooncol. 2017 Apr;132(2):323-331. doi: 10.1007/s11060-017-2372-5. Epub 2017 Jan 16.
2
Patterns of progression in pediatric patients with high-grade glioma or diffuse intrinsic pontine glioma treated with Bevacizumab-based therapy at diagnosis.诊断时接受以贝伐单抗为基础治疗的小儿高级别胶质瘤或弥漫性脑桥内在型胶质瘤患者的疾病进展模式
J Neurooncol. 2015 Feb;121(3):591-8. doi: 10.1007/s11060-014-1671-3. Epub 2014 Nov 30.
3
Diffuse intrinsic pontine glioma in children and adolescents: a single-center experience.儿童和青少年弥漫性脑桥内在型胶质瘤:单中心经验
Childs Nerv Syst. 2014 Jun;30(6):1061-6. doi: 10.1007/s00381-014-2359-x. Epub 2014 Jan 14.
4
Brain stem tumors in children and adolescents: single institutional experience.儿童和青少年脑干肿瘤:单机构经验
Childs Nerv Syst. 2013 Aug;29(8):1321-31. doi: 10.1007/s00381-013-2137-1. Epub 2013 May 12.
5
Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience.复发性弥漫性内在脑桥胶质瘤的治疗:MD 安德森癌症中心的经验。
J Neurooncol. 2012 Jan;106(2):391-7. doi: 10.1007/s11060-011-0677-3. Epub 2011 Aug 20.
6
Brain stem gliomas: therapeutic options at time of recurrence.脑干胶质瘤:复发时的治疗选择
Pediatr Neurosurg. 1996;24(4):211-6. doi: 10.1159/000121040.

Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study.

作者信息

Cooney Tabitha, Lane Adam, Bartels Ute, Bouffet Eric, Goldman Stewart, Leary Sarah E S, Foreman Nicholas K, Packer Roger J, Broniscer Alberto, Minturn Jane E, Shih Chie-Schin, Chintagumpala Murali, Hassall Tim, Gottardo Nicholas G, Dholaria Hetal, Hoffman Lindsey, Chaney Brooklyn, Baugh Joshua, Doughman Renee, Leach James L, Jones Blaise V, Fouladi Maryam, Warren Katherine E, Monje Michelle

机构信息

Departments of Neurology, Neurosurgery and Pediatrics, Lucile Packard Children's Hospital at Stanford, Stanford, California; Department of Pediatrics, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Canada; Departments of Hematology-Oncology, Neuro-Oncology & Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois; Department of Hematology/Oncology, Seattle Children's Hospital, Seattle, Washington; Departments of Pediatrics, University of Colorado and Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Denver, Colorado; Center for Neuroscience and Behavioral Medicine, Children's National Medical Center, Washington D.C.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Section of Pediatric Hematology/Oncology, Riley Children's Hospital, Indianapolis, Indiana; Department of Pediatrics, Texas Children's Hospital, Houston, Texas; Lady Cilento Children's Hospital, Brisbane, Australia; Princess Margaret Hospital for Children and Telethon Kid's Institute, Subiaco, Australia; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland.

出版信息

Neuro Oncol. 2017 Sep 1;19(9):1279-1280. doi: 10.1093/neuonc/nox107.

DOI:10.1093/neuonc/nox107
PMID:28821206
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5570207/
Abstract
摘要